Allspring Global Investments Holdings, LLC Vir Biotechnology, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$7.76 - $10.29 $25,864 - $34,296	-3,333 Reduced 36.4%	5,824 $58,000
Q3 2023 Oct 27, 2023	BUY	$9.14 - $24.62 $83,694 - $225,445	9,157 New	9,157 $85,000
Q2 2023 Jul 18, 2023	SELL	$23.2 - $27.29 $4.22 Million - $4.96 Million	-181,697 Reduced 92.92%	13,854 $339,000
Q1 2023 Apr 13, 2023	BUY	$22.26 - $30.85 $1.23 Million - $1.7 Million	55,209 Added 39.34%	195,551 $4.55 Million
Q4 2022 Jan 23, 2023	BUY	$19.96 - $28.22 $2.56 Million - $3.62 Million	128,106 Added 1046.96%	140,342 $3.55 Billion
Q3 2022 Oct 26, 2022	BUY	$18.26 - $31.1 $108,829 - $185,356	5,960 Added 94.96%	12,236 $235,000
Q2 2022 Jul 25, 2022	SELL	$19.08 - $26.7 $2.45 Million - $3.43 Million	-128,297 Reduced 95.34%	6,276 $159,000
Q1 2022 May 02, 2022	BUY	$21.19 - $40.01 $2.44 Million - $4.6 Million	114,920 Added 584.75%	134,573 $3.46 Million
Q4 2021 Jan 28, 2022	BUY	$30.97 - $54.03 $608,653 - $1.06 Million	19,653 New	19,653 $822,000

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$119 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$117 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$93.5 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$40.1 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$25.4 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account